Skip to main content
. Author manuscript; available in PMC: 2023 Sep 5.
Published in final edited form as: Int J Drug Policy. 2022 Jan 21;102:103580. doi: 10.1016/j.drugpo.2022.103580

Table 2.

Characteristics of participants diagnosed with chronic HCV in subgroups who started HCV treatment and who did not, N= 47

Characteristics Not started treatment
N = 13 (27.7%)
Initiated treatment
N = 34 (72.3%)
P-value
Male sex 13 (100) 31 (91.2) 0.2
Mean age [SD], Years 45.3 [13.2] 46.3 [15.1] -
Ever being homeless 9 (69.2) 29 (85.3) 0.2
Low education (primary or less) 8 (61.5) 22 (64.7) 0.8
living with their spouse (no) 11 (84.6) 31 (91.2) 0.5
Having an employment (no) 9 (69.2) 23 (67.6) 0.8
Monthly income (Under 1,000,000T (<$100)) 12 (92.3) 26 (76.5) 0.2
Injecting frequency reported in the last 3 months (at least weekly) 9 (69.2) 20 (58.8) 0.5
Injected with another person in the last 12 months 11 (84.6) 27 (79.4) 0.6
Reported OAT in last 12 months 10 (76.9) 25 (73.5) 0.7

Abbreviations- SD; standard deviation, OAT; opioid agonist therapy